105 related articles for article (PubMed ID: 18161841)
1. Predicting and monitoring colitis development in mice by micro-computed tomography.
Fredin MF; Hultin L; Hyberg G; Rehnström E; Hultgren Hörnquist E; Melgar S; Jansson L
Inflamm Bowel Dis; 2008 Apr; 14(4):491-9. PubMed ID: 18161841
[TBL] [Abstract][Full Text] [Related]
2. Longitudinal quantification of inflammation in the murine dextran sodium sulfate-induced colitis model using μPET/CT.
Hindryckx P; Staelens S; Devisscher L; Deleye S; De Vos F; Delrue L; Peeters H; Laukens D; De Vos M
Inflamm Bowel Dis; 2011 Oct; 17(10):2058-64. PubMed ID: 21910167
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Quantitative Imaging Biomarkers in the DSS Colitis Model.
Beltzer A; Kaulisch T; Bluhmki T; Schoenberger T; Stierstorfer B; Stiller D
Mol Imaging Biol; 2016 Oct; 18(5):697-704. PubMed ID: 26884057
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive Longitudinal Study of a Magnetic Resonance Imaging Biomarker for the Quantification of Colon Inflammation in a Mouse Model of Colitis.
Bianchi A; Bluhmki T; Schönberger T; Kaaru E; Beltzer A; Raymond E; Wunder A; Thakker P; Stierstorfer B; Stiller D
Inflamm Bowel Dis; 2016 Jun; 22(6):1286-95. PubMed ID: 27104818
[TBL] [Abstract][Full Text] [Related]
5. Chronic Model of Inflammatory Bowel Disease in IL-10
Wang H; Vilches-Moure JG; Cherkaoui S; Tardy I; Alleaume C; Bettinger T; Lutz A; Paulmurugan R
Theranostics; 2019; 9(21):6031-6046. PubMed ID: 31534535
[No Abstract] [Full Text] [Related]
6. Translational 18F-FDG PET/CT imaging to monitor lesion activity in intestinal inflammation.
Bettenworth D; Reuter S; Hermann S; Weckesser M; Kerstiens L; Stratis A; Nowacki TM; Ross M; Lenze F; Edemir B; Maaser C; Pap T; Koschmieder S; Heidemann J; Schäfers M; Lügering A
J Nucl Med; 2013 May; 54(5):748-55. PubMed ID: 23516311
[TBL] [Abstract][Full Text] [Related]
7. Longitudinal PET/CT evaluation of TNBS-induced inflammatory bowel disease rat model.
Seoane-Viaño I; Gómez-Lado N; Lázare-Iglesias H; Barreiro-de Acosta M; Silva-Rodríguez J; Luzardo-Álvarez A; Herranz M; Otero-Espinar F; Antúnez-López JR; Lamas MJ; Aguiar P; Fernández-Ferreiro A; Ruibal Á
Int J Pharm; 2018 Oct; 549(1-2):335-342. PubMed ID: 30081226
[TBL] [Abstract][Full Text] [Related]
8. Detection and characterization of murine colitis and carcinogenesis by molecularly targeted contrast-enhanced ultrasound.
Brückner M; Heidemann J; Nowacki TM; Cordes F; Stypmann J; Lenz P; Gohar F; Lügering A; Bettenworth D
World J Gastroenterol; 2017 Apr; 23(16):2899-2911. PubMed ID: 28522908
[TBL] [Abstract][Full Text] [Related]
9. Dextran sulphate sodium induces acute colitis and alters hepatic function in hamsters.
Karlsson A; Jägervall A; Pettersson M; Andersson AK; Gillberg PG; Melgar S
Int Immunopharmacol; 2008 Jan; 8(1):20-7. PubMed ID: 18068096
[TBL] [Abstract][Full Text] [Related]
10. Deficiency of Protein Tyrosine Phosphatase Non-Receptor Type 2 in Intestinal Epithelial Cells Has No Appreciable Impact on Dextran Sulphate Sodium Colitis Severity But Promotes Wound Healing.
Kasper SH; Spalinger MR; Leonardi I; Gerstgrasser A; Raselli T; Gottier C; Atrott K; Frey-Wagner I; Fischbeck-Terhalle A; Rogler G; Scharl M
Digestion; 2016; 93(4):249-59. PubMed ID: 27115526
[TBL] [Abstract][Full Text] [Related]
11. Quantitative phenotyping of inflammatory bowel disease in the IL-10-deficient mouse by use of noninvasive magnetic resonance imaging.
Michael S; Keubler LM; Smoczek A; Meier M; Gunzer F; Pöhlmann C; Krause-Buchholz U; Hedrich HJ; Bleich A
Inflamm Bowel Dis; 2013 Jan; 19(1):185-93. PubMed ID: 22570250
[TBL] [Abstract][Full Text] [Related]
12. Comparison of experimental mouse models of inflammatory bowel disease.
Oh SY; Cho KA; Kang JL; Kim KH; Woo SY
Int J Mol Med; 2014 Feb; 33(2):333-40. PubMed ID: 24285285
[TBL] [Abstract][Full Text] [Related]
13. The role of the complement and contact systems in the dextran sulfate sodium-induced colitis model: the effect of C1 inhibitor in inflammatory bowel disease.
Lu F; Fernandes SM; Davis AE
Am J Physiol Gastrointest Liver Physiol; 2010 Jun; 298(6):G878-83. PubMed ID: 20338925
[TBL] [Abstract][Full Text] [Related]
14. CCL2 (pM levels) as a therapeutic agent in Inflammatory Bowel Disease models in mice.
Maharshak N; Hart G; Ron E; Zelman E; Sagiv A; Arber N; Brazowski E; Margalit R; Elinav E; Shachar I
Inflamm Bowel Dis; 2010 Sep; 16(9):1496-504. PubMed ID: 20222120
[TBL] [Abstract][Full Text] [Related]
15. Psychological stress reactivates dextran sulfate sodium-induced chronic colitis in mice.
Melgar S; Engström K; Jägervall A; Martinez V
Stress; 2008 Sep; 11(5):348-62. PubMed ID: 18666024
[TBL] [Abstract][Full Text] [Related]
16. Metallothionein overexpression does not protect against inflammatory bowel disease in a murine colitis model.
Oz HS; Chen T; de Villiers WJ; McClain CJ
Med Sci Monit; 2005 Mar; 11(3):BR69-73. PubMed ID: 15735556
[TBL] [Abstract][Full Text] [Related]
17. Westernized high-fat diet accelerates weight loss in dextran sulfate sodium-induced colitis in mice, which is further aggravated by supplementation of heme.
van der Logt EM; Blokzijl T; van der Meer R; Faber KN; Dijkstra G
J Nutr Biochem; 2013 Jun; 24(6):1159-65. PubMed ID: 23246033
[TBL] [Abstract][Full Text] [Related]
18. Dextran sulfate sodium-induced acute colitis impairs dermal lymphatic function in mice.
Agollah GD; Wu G; Peng HL; Kwon S
World J Gastroenterol; 2015 Dec; 21(45):12767-77. PubMed ID: 26668501
[TBL] [Abstract][Full Text] [Related]
19. Magnetic resonance imaging of experimental mouse colitis and association with inflammatory activity.
Larsson AE; Melgar S; Rehnström E; Michaëlsson E; Svensson L; Hockings P; Olsson LE
Inflamm Bowel Dis; 2006 Jun; 12(6):478-85. PubMed ID: 16775491
[TBL] [Abstract][Full Text] [Related]
20. Chitosan oligosaccharide as potential therapy of inflammatory bowel disease: therapeutic efficacy and possible mechanisms of action.
Yousef M; Pichyangkura R; Soodvilai S; Chatsudthipong V; Muanprasat C
Pharmacol Res; 2012 Jul; 66(1):66-79. PubMed ID: 22475725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
